Overview
Yongyong Ma practices in Wenzhou, China. Ma is rated as an Experienced expert by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Their top areas of expertise are Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, and Non-Hodgkin Lymphoma.
Their clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Diffuse Large B-Cell Lymphoma (DLBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- B-Cell LymphomaMa isExperienced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Graft Versus Host Disease (GvHD)
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaMa isExperienced. Learn about Multiple Myeloma.